Nicholas Arpaia

Department of Microbiology & Immunology, Columbia University

Affiliated withColumbia University Columbia College

Research Area

Biography

Nicholas Arpaia has not added Biography.
If you are Nicholas Arpaia and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2024

Other Publications

Article	Year
Clonal Bifurcation of Foxp3 Expression Visualized in Thymocytes and T Cells. ImmunoHorizons\| PubMed ID: 29707696	2018
Treg Cells: A LAGging Hand Holds the Double-Edged Sword of the IL-23 Axis. Immunity\| PubMed ID: 30134197	2018
Glycans for good. Science immunology\| PubMed ID: 30341146	2018
Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nature medicine\| PubMed ID: 31270504	2019
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Science translational medicine\| PubMed ID: 32051224	2020
Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. The Journal of clinical investigation\| PubMed ID: 33905375	2021
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer cell\| PubMed ID: 33930309	2021
CXCL13 shapes tertiary lymphoid structures and promotes response to immunotherapy in bladder cancer. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 33972155	2021
The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis. Gastroenterology\| PubMed ID: 34883119	2022
A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nature biotechnology\| PubMed ID: 35301496	2022
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer. The Journal of clinical investigation\| PubMed ID: 35503263	2022
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature\| PubMed ID: 36198802	2022
Engineering bacteria as interactive cancer therapies. Science (New York, N.Y.)\| PubMed ID: 36423303	2022
Regulation of the alveolar regenerative niche by amphiregulin-producing regulatory T cells. The Journal of experimental medicine\| PubMed ID: 36534084	2023
Dietary tryptophan deficiency promotes gut RORγt Treg cells at the expense of Gata3 Treg cells and alters commensal microbiota metabolism. Cell reports\| PubMed ID: 36840944	2023
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity. Science advances\| PubMed ID: 36888717	2023
Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development targeting mucosal immunity. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 37116288	2023
Probiotic-guided CAR-T cells for solid tumor targeting. Science (New York, N.Y.)\| PubMed ID: 37824640	2023
Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. Nature communications\| PubMed ID: 38245513	2024